my five stocks, goldman sachs, gs, eog, tesla, tsla, facebook, celgene. >> i like this. go over this. eog, one of the faster growing oil companies, tesla, we know that as the future is now car company. celgene, the chief executive was on earlier this morning, technology, biotech, auto, oil, finance, that's exactly what we want. bingo! stick with cramer. ♪ ♪ ♪ i'm dr. kelsey mcneely and some day you might be calling me an energy farmer. ♪ energy lives here. thithis is the new new york.e? think again. we are building new airports all across the state. new roads and bridges. new mass transit. new business friendly environment. new lower taxes. and new university partnerships to grow the businesses of tomorrow today. learn more at esd.ny.gov over hereno!ver here! (dog barking) whoever threw it has to go get it. not me! somebody will get it... ♪ (dog barking) anyone can dream. making it a reality is the hard part. from the b-2 to the upcoming b-21, northrop grumman stealth bombers give america an advantage in a turbulent world. and we're looking for a few dreamers to join us.

for more, we are joined by celgene executive chairman, robert dwch robert gugin and meg smith.u met with president trump. he started out by saying drug prices are too high. what did you take away from that? >> a lot of work with health care reform. so important to our economy and citizens. >> the president was engaged, asked lots of questions and really wanted suggestions. after that meeting, we have had significant follow-up. action oriented. i think most of the people were very optimistic that we will have an engaged process as we go forward. >> at the same time, trump is saying even at the jpmorgan health care conference in january, saying the drug indoes sfri is getting away with murder when it comes to their prices. >> are you concerned about legislation on prices? >> you always have to be concerned. we live in a value-based world. we have so many systems that we receive fair value for what we do for patients. we're successful because of that. we want to make sure people recognize. we support value-based prices. we are willing to get paid for performances. we have specific

celgene being driven by one drug, really missing expectations. that was otezla. seeing some pricing pressure which is a big question for the whole class right now. politics, will we see the government step in or is it just the focus from the private side, from the payers driving all this pressure. >> meg, thank you very much. >>> josh brown in chicago, you own both amgen and bristol-myers. >> i do. it's a little bit of a bar bell. amgen is a darling, very close to all-time highs almost all the time. and then on the other side of that barbell is bristol, which really looks like somebody dropped a piano on it a few months back, but it's starting to recover. the technicals are getting better, the news flow is getting better. so i like both holdings a lot. i don't expect them to act in the same way but i think both can work. i want to make a very quick point broadly speaking on the sector. on the show i spent a few months arguing with people should you get out of health care because of trump tweeting. it was the most ludicrous thing i've ever heard until the next day

. >>> when we come back, an exclusive with celgenes executive chairman who's met with the president on biotech and pharma under the trump white house. still awaiting the press briefing at 1:30. we'll get more clarity on the white house tax plan. back after a break. >>> we had a very successful meeting last night and i think it's clear that the house, the senate, the administration are all on the same page. that tax reform is a major priority to boost the economy. >> that was treasury secretary steven mnuchin this morning ahead of the white house tax reform announcement. we're going to keep an eye on capitol hill where speaker ryan and the gop leadership will be holding their first news conference in a couple of weeks. of course they have been on recess. the congressional agenda this week, government funding, health care, tax reform, the speaker did say this morning, quote, they have gotten a sneak peek and we're in agreement on 80%. and that 20% we're in the same ballpark. as the story will be about whether the house and the white house see eye to eye. >> there are a lot of details. i